Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Vaccines
|
February 26, 2022
What Drives the Value of a <i>Shigella</i> Vaccine?
William P Hausdorff, Suzanne Scheele, Birgitte K Giersing
Vaccine
|
October 17, 2017
Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy
Divya Hosangadi, Peter G Smith, Birgitte K Giersing
Vaccine
|
April 24, 2016
Status of vaccine research and development of vaccines for Staphylococcus aureus
Birgitte K Giersing, Sana S Dastgheyb, Kayvon Modjarrad, et al.
Vaccine
|
March 20, 2016
Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7-9th Sep 2015
Birgitte K Giersing, Kayvon Modjarrad, David C Kaslow, et al.
Vaccine
|
January 21, 2018
WHO consultation on ETEC and Shigella burden of disease, Geneva, 6-7th April 2017: Meeting report
Divya Hosangadi, Peter G Smith, David C Kaslow, et al.
Vaccine
|
March 7, 2017
Report from the World Health Organization's third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016
Birgitte K Giersing, Johan Vekemans, Samantha Nava, et al.
Vaccine
|
June 13, 2006
Potency assay design for adjuvanted recombinant proteins as malaria vaccines
Birgitte K Giersing, Filip Dubovsky, Allan Saul, et al.
Sexual Health
|
September 3, 2019
Advancing vaccine development for gonorrhoea and the Global STI Vaccine Roadmap
Sami L Gottlieb, Ann E Jerse, Sinead Delany-Moretlwe, et al.
Vaccine
|
March 18, 2017
Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25-26 April 2016
Birgitte K Giersing, Ruth A Karron, Johan Vekemans, et al.
Vaccine
|
April 25, 2016
The 2016 Vaccine Development Pipeline: A special issue from the World Health Organization Product Development for Vaccine Advisory Committee (PDVAC)
Birgitte K Giersing, Kayvon Modjarrad, David C Kaslow, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Vaccines
|
February 26, 2022
What Drives the Value of a <i>Shigella</i> Vaccine?
William P Hausdorff, Suzanne Scheele, Birgitte K Giersing
Vaccine
|
October 17, 2017
Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy
Divya Hosangadi, Peter G Smith, Birgitte K Giersing
Vaccine
|
April 24, 2016
Status of vaccine research and development of vaccines for Staphylococcus aureus
Birgitte K Giersing, Sana S Dastgheyb, Kayvon Modjarrad, et al.
Vaccine
|
March 20, 2016
Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7-9th Sep 2015
Birgitte K Giersing, Kayvon Modjarrad, David C Kaslow, et al.
Vaccine
|
January 21, 2018
WHO consultation on ETEC and Shigella burden of disease, Geneva, 6-7th April 2017: Meeting report
Divya Hosangadi, Peter G Smith, David C Kaslow, et al.
Vaccine
|
March 7, 2017
Report from the World Health Organization's third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016
Birgitte K Giersing, Johan Vekemans, Samantha Nava, et al.
Vaccine
|
June 13, 2006
Potency assay design for adjuvanted recombinant proteins as malaria vaccines
Birgitte K Giersing, Filip Dubovsky, Allan Saul, et al.
Sexual Health
|
September 3, 2019
Advancing vaccine development for gonorrhoea and the Global STI Vaccine Roadmap
Sami L Gottlieb, Ann E Jerse, Sinead Delany-Moretlwe, et al.
Vaccine
|
March 18, 2017
Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25-26 April 2016
Birgitte K Giersing, Ruth A Karron, Johan Vekemans, et al.
Vaccine
|
April 25, 2016
The 2016 Vaccine Development Pipeline: A special issue from the World Health Organization Product Development for Vaccine Advisory Committee (PDVAC)
Birgitte K Giersing, Kayvon Modjarrad, David C Kaslow, et al.
Page
of 4